“…Medical imaging classification plays a substantial role to identify irregularity in different organs of the body, such as blood cancer (Abbas et al, 2018, 2018a, 2018b, 2018c; Rehman, Abbas, Saba, Mahmood, & Kolivand, 2018; Rehman, Abbas, Saba, Mehmood, Mahmood, et al, 2018; Rehman, Abbas, Saba, Rahman, Mehmood, et al, 2018), lung cancer (Khan, Nazir, et al, 2019; Saba, Khan, Islam, et al, 2019; Saba, Khan, Rehman, et al, 2019), brain tumor (Khan, Lali, et al, 2019; Rehman, Khan, Saba, et al, 2021), breast cancer (Mughal, Muhammad, Sharif, Saba, & Rehman, 2017; Mughal, Muhammad, Sharif, Rehman, & Saba, 2018; Marie‐Sainte, Saba, et al, 2019; Saba, Sameh, Khan, Shad, & Sharif, 2019), stomach cancer (Khan, Javed, Sharif, Saba, & Rehman, 2019, Khan, Sharif, et al, 2019), skin cancer (Javed, Rahim, Saba, & Rashid, 2019; Javed, Rahim, & Saba, 2019; Javed, Rahim, Saba, & Rehman, 2020; Javed, Saba, Shafry, & Rahim, 2020; Khan, Akram, et al, 2019; Khan, Javed, et al, 2019; Khan, Sharif, et al, 2019; Saba, Khan, Rehman, et al, 2019), Retinal image analysis (Jamal, Hazim Alkawaz, Rehman, & Saba, 2017; Saba, Bokhari, Sharif, Yasmin, & Raza, 2018; Ullah et al, 2019) and so on. The abnormality of the organ often results in rapid tumor development, which is the primary cause of death worldwide (Fahad, Khan, Saba, Rehman, & Iqbal, 2018; Rahim, Norouzi, Rehman, & Saba, 2017; Rahim, Rehman, Kurniawan, & Saba, 2017; Saba, Rehman, Mehmood, Kolivand, & Sharif, 2018; Saba, Bokhari, Sharif, Yasmin, & Raza, 2018; Saba, Al‐Zahrani, & Rehman, 2012; Ullah et al, 2019; Yousaf, Mehmood, Saba, et al, 2019; Yousaf, Mehmood, Awan, et al, 2019).…”